Europe Cancer Tissue Diagnostics Market Growth and Recent Trends by 2027

Historic Data: 2016-2017   |   Base Year: 2018   |   Forecast Period: 2019-2027

Europe Cancer Tissue Diagnostics Market to 2027 - Regional Analysis and Forecasts by Test Type (Immunohistochemical Tests and In Situ Hybridization Tests), and Country

  • Report Code : TIPRE00006840
  • Category : Life Sciences
  • No. of Pages : 137
Buy Now

Cancer Tissue Diagnostics market in Europe is expected to grow from US$ 512.73 Mn in the year 2018 and is expected to reach US$ 830.28 Mn by 2027 growing at a CAGR of 5.8% over the forecast period.

The growth of the market is driven by the factors such as increasing number of cancer cases and rising geriatric population. On the other hand, high cost of cancer diagnostics in some of the European countries is limiting the growth of market is likely to have a negative impact on the growth of the market in the coming years.

Cancer is among the leading cause of deaths across Europe globe and is profoundly affecting the quality of life. Thus, cancer will be a burden on society if not diagnosed and treated on time. According to the World Health Organization in 2018, approximately 9.6 million deaths across the globe were due to cancer. Additionally, cancer is found to be commonly prevalent in European countries as well. As per the Cancer Research UK, in 2016, around 163,444 deaths in the UK were due to cancer.

The World Health Organization (WHO) also reported that with over 3.7 million new cases and 1.9 million deaths each year, cancer is the second most important cause of morbidity and death in Europe. Moreover, Europe comprises of one-eighth of the total world population, however approximately a quarter of global cancer cases with 3.7 million new patients are from Europe, suggesting high incidence rate of cancer in the region. Furthermore, the data also suggests that 40% of these cancer cases are preventable with appropriate diagnosis at early stages and correct treatment and medication.

The Spain Cancer Tissue Diagnostics market is expected to grow at highest rate during the forecast period owing to various cancer research studies undergoing in the country, increasing number of cancer patients in the country, and various solutions undertaken to reduce the financial burden due to cancer on the country. Moreover, the country also is the fastest growing among other European countries owing to the increasing medical tourism flourishing in Spain.

Spain Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

  • This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
 

EUROPE CANCER TISSUE DIAGNOSTICS – MARKET SEGMENTATION

By Test Type

  • Immunohistochemical Tests
    • Breast Cancer
    • Colorectal Cancer
    • Prostate Cancer
    • Stomach Cancer
    • Others
  • In Situ Hybridization Tests
    • Breast Cancer
    • Lung Cancer
    • Bladder Cancer
    • Others

By Country

  • France
  • Germany
  • UK
  • Italy
  • Spain

Companies Mentioned

  • F. Hoffmann-La Roche Ltd
  • Thermo Fisher Scientific Inc.
  • Bio Rad Laboratories Inc.
  • Abbott
  • Enzo Life Sciences, Inc.
  • Agilent Technologies, Inc.
  • Cancer Genetics Inc.
  • Merck KGaA (Sigma-Aldrich Co. LLC)
  • Danaher
  • Abcam plc.

Europe Cancer Tissue Diagnostics Report Scope

Report Attribute Details
Market size in 2018 US$ 512.73 Million
Market Size by 2027 US$ 830.28 Million
Global CAGR (2019 - 2027) 5.8%
Historical Data 2016-2017
Forecast period 2019-2027
Segments Covered By Test Type
  • Immunohistochemical Tests and In Situ Hybridization Tests
Regions and Countries Covered Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Market leaders and key company profiles
  • F. Hoffmann-La Roche Ltd
  • Thermo Fisher Scientific Inc.
  • Bio Rad Laboratories Inc.
  • Abbott
  • Enzo Life Sciences, Inc.
  • Agilent Technologies, Inc.
  • Cancer Genetics Inc.
  • Merck KGaA (Sigma-Aldrich Co. LLC)
  • Danaher
    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset
    europe-cancer-tissue-diagnostics-market-report-deliverables-img1
    europe-cancer-tissue-diagnostics-market-report-deliverables-img2
    Report Coverage

    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered

    Segment Covered

    Test Type, and Country

    Regional Scope

    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope

    Country Scope

    UK, Germany, France, Italy, Russia

    Trends and growth analysis reports related to Life Sciences : READ MORE..   

    Europe Cancer Tissue Diagnostics Market
    Connect With Expert

    The List of Companies - Europe Cancer Tissue Diagnostics Market

    1. F. Hoffmann-La Roche Ltd
    2. Thermo Fisher Scientific Inc.
    3. Bio Rad Laboratories Inc.
    4. Abbott
    5. Enzo Life Sciences, Inc.
    6. Agilent Technologies, Inc.
    7. Cancer Genetics Inc.
    8. Merck KGaA (Sigma-Aldrich Co. LLC)
    9. Danaher
    10. Abcam plc.
    europe-cancer-tissue-diagnostics-market-cagr